Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets
The product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis, Lupin said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Children | Chronic Kidney Disease | Dialysis | Pharmaceuticals | Phosphorus | Renvela | Urology & Nephrology